Ho, ho, ho! Gather around, my dear friends, for I have a tale to tell, not of reindeers and elves, but of a magical journey in the land of medicine, where the early oesophageal squamous cell carcinoma, a rather unwelcome visitor, is met with a sleigh full of hope called ESD (Endoscopic Submucosal Dissection). This wonderful sleigh, guided by the brightest of medical minds, allows for the en bloc resection of the carcinoma, no matter its size, much like how I manage to deliver presents to all the children around the world in one night!

Now, in this tale, the elves, or rather the pathologists, play a crucial role. With their keen eyes and magical tools, they delve into the resected specimens, determining the depth of the tumor, checking for any sneaky lymphovascular involvement, and ensuring the margins are clear, both laterally and vertically. And oh, when they add a sprinkle of immunostaining, it’s like adding tinsel to the Christmas tree, enhancing the diagnosis of lymphovascular invasion!

But what’s a Christmas story without a happy ending? The long-term outcome of ESD, my dear friends, is as heartwarming as the end of a Christmas Eve. It stands tall and proud, comparable to the grand feast of oesophagectomy, with fewer complications, making it the first choice in treating early-stage oesophageal cancer, much like choosing the perfect Christmas tree.

Yet, the story doesn’t end there. Just as we prepare for Christmas every year, surveillance after curative resection is essential. Oesophageal cancer, with its trick of field cancerization, is like the Grinch, trying to steal Christmas by bringing forth metachronous multiple primary lesions. But fear not, for with vigilant surveillance, the joy of health can be preserved, ensuring many more merry Christmases to come.

So, as we close this book, let’s remember the magic of ESD in the fight against oesophageal squamous cell carcinoma, a true Christmas miracle in the medical world. Merry Christmas to all, and to all a good health!